Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ITMR

Itamar Medical (ITMR) Stock Price, News & Analysis

Itamar Medical logo

About Itamar Medical Stock (NASDAQ:ITMR)

Key Stats

Today's Range
$30.87
$30.87
50-Day Range
$30.54
$30.87
52-Week Range
$16.36
$30.91
Volume
N/A
Average Volume
90,796 shs
Market Capitalization
$497.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ITMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Itamar Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ITMR Stock News Headlines

ITMR Historical Data
Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
Read Your Way Around the World
Find the Best Medical Schools
Sarit Packer and Itamar Srulovich
ZOLL Announces Closing of Acquisition of Itamar Medical
See More Headlines

ITMR Stock Analysis - Frequently Asked Questions

Itamar Medical Ltd. (NASDAQ:ITMR) released its quarterly earnings data on Thursday, November, 18th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.32. The firm had revenue of $13.57 million for the quarter, compared to analyst estimates of $13.70 million.

The following companies are subsidiaries of Itamar Medical: I.M.E. 2016 B.V., Itamar Medical Inc., and Itamar Medical Japan Co. Ltd..

Based on aggregate information from My MarketBeat watchlists, some other companies that Itamar Medical investors own include AbbVie (ABBV), Avino Silver & Gold Mines (ASM), Gilead Sciences (GILD), Cheniere Energy (LNG), M&T Bank (MTB), Energy Transfer (ET) and International Business Machines (IBM).

Company Calendar

Last Earnings
11/18/2021
Today
9/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ITMR
CIK
1613170
Fax
N/A
Employees
257
Year Founded
1997

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$41.03 million
Price / Sales
12.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
16,108,000
Free Float
N/A
Market Cap
$497.25 million
Optionable
Not Optionable
Beta
0.73

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ITMR) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners